Whittier Trust Co. Has $10.47 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Posted by Geri Gentry on Jul 7th, 2026

Whittier Trust Co. boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 10.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 148,659 shares of the company’s stock after purchasing an additional 13,642 shares during the period. Whittier Trust Co.’s holdings in GE HealthCare Technologies were worth $10,466,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth $27,000. Montag A & Associates Inc. increased its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC raised its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 262 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on GEHC. JPMorgan Chase & Co. decreased their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lowered their price target for the stock from $75.00 to $69.00 in a research report on Thursday, May 21st. Mizuho reduced their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Finally, BTIG Research dropped their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Ten research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $80.20.

Get Our Latest Stock Analysis on GE HealthCare Technologies

GE HealthCare Technologies Price Performance

NASDAQ:GEHC traded up $0.37 during mid-day trading on Tuesday, reaching $65.21. The stock had a trading volume of 588,915 shares, compared to its average volume of 4,350,446. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The stock has a market capitalization of $29.67 billion, a PE ratio of 15.61, a P/E/G ratio of 1.78 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock has a 50-day simple moving average of $63.60 and a two-hundred day simple moving average of $73.09.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period in the prior year, the business posted $1.01 EPS. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini bought 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the acquisition, the director directly owned 13,702 shares in the company, valued at $863,363.02. The trade was a 7.87% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last ninety days. 0.36% of the stock is owned by insiders.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.